Literature DB >> 19556153

Comparison of 2002 TNM nodal status with lymph node density in node-positive patients after radical cystectomy for bladder cancer: analysis by the number of lymph nodes removed.

In Gab Jeong1, Jinsung Park, Kanghyon Song, Jae Y Ro, Cheryn Song, Jun Hyuk Hong, Hanjong Ahn, Choung-Soo Kim.   

Abstract

OBJECTIVE: Because 2002 TNM pathologic nodal (pN) status was established in patients from whom a relatively small number of lymph nodes had been removed, it is necessary to validate this staging system in current clinical practice, in which the removal of more lymph nodes is recommended during radical cystectomy and pelvic lymphadenectomy. We assessed the ability of lymph node density (LND) and 2002 TNM pathologic nodal (pN) status to predict disease-specific survival (DSS) in node-positive patients after radical cystectomy for bladder cancer, and investigated whether these factors were affected by the number of lymph nodes removed during pelvic lymphadenectomy.
MATERIALS AND METHODS: We retrospectively evaluated outcomes in 130 patients with nodal metastases after radical cystectomy performed between 1989 and 2006. Patients were divided into 2 subgroups based on the median number of lymph nodes removed, those with <15 and those with ≥ 15 lymph nodes removed. The effect of several variables on DSS was assessed.
RESULTS: The overall 5-year DSS rate was 38.5%. Multivariate analysis showed that in the entire cohort, LND (HR = 2.28, 1.04-5.03, P = 0.041) and the use of adjuvant chemotherapy (HR = 2.68, 1.42-5.06, P = 0.002) were significant predictors of DSS. In patients with <15 lymph nodes removed, pN status (HR = 5.19, 1.24-21.75, P = 0.024) and use of adjuvant chemotherapy (HR = 6.23, 2.32-16.73, P < 0.001) were independent predictors of DSS. In patients with ≥ 15 lymph nodes removed, however, only LND (HR = 4.08, 1.10-15.10, P = 0.036) was a predictor of DSS.
CONCLUSIONS: LND was an independent predictor of DSS in node-positive patients. However, when small numbers of lymph nodes were removed, TNM pN status was a better predictor than LND. These findings suggest that abilities of TNM pN status and LND in node-positive patients to predict DSS could be affected by the total number of lymph nodes removed.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19556153     DOI: 10.1016/j.urolonc.2009.04.006

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  6 in total

1.  Does the greater number of lymph nodes removed during standard lymph node dissection predict better patient survival following radical cystectomy?

Authors:  Jinsung Park; Seongcheol Kim; In Gab Jeong; Cheryn Song; Jun Hyuk Hong; Choung-Soo Kim; Hanjong Ahn
Journal:  World J Urol       Date:  2011-01-15       Impact factor: 4.226

2.  Role of pelvic lymphadenectomy in the treatment of bladder cancer: a mini review.

Authors:  Ja Hyeon Ku
Journal:  Korean J Urol       Date:  2010-06-21

3.  Clinical prognosticators of survival in patients with urothelial carcinoma of the bladder and lymph node metastases after cystectomy with curative intent.

Authors:  Thomas Horn; Sebastian C Schmid; Anna K Seitz; Jessica Grab; Petra Wolf; Bernhard Haller; Margitta Retz; Tobias Maurer; Michael Autenrieth; Hubert R Kübler; Jürgen E Gschwend
Journal:  World J Urol       Date:  2014-07-10       Impact factor: 4.226

Review 4.  Lymph node density as a prognostic variable in node-positive bladder cancer: a meta-analysis.

Authors:  Ja Hyeon Ku; Minyong Kang; Hyung Suk Kim; Chang Wook Jeong; Cheol Kwak; Hyeon Hoe Kim
Journal:  BMC Cancer       Date:  2015-06-02       Impact factor: 4.430

5.  Downregulation of DAB2IP results in cell proliferation and invasion and contributes to unfavorable outcomes in bladder cancer.

Authors:  Yi-Jun Shen; Zhao-Lu Kong; Fang-Ning Wan; Hong-Kai Wang; Xiao-Jie Bian; Hua-Lei Gan; Chao-Fu Wang; Ding-Wei Ye
Journal:  Cancer Sci       Date:  2014-05-08       Impact factor: 6.716

6.  Adjuvant chemotherapy versus observation after radical cystectomy in patients with node-positive bladder cancer.

Authors:  Sahyun Pak; Dalsan You; In Gab Jeong; Cheryn Song; Jae-Lyun Lee; Bumsik Hong; Jun Hyuk Hong; Choung-Soo Kim; Hanjong Ahn
Journal:  Sci Rep       Date:  2019-06-05       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.